Skip to main content

Subcorneal and Intraepidermal Immunobullous Dermatoses

  • Chapter
  • First Online:
Hospital-Based Dermatopathology

Abstract

The diseases described in this chapter are the intraepidermal bullous dermatoses exhibiting acantholysis as the main and common histologic feature. The first group are pemphiguses or acquired autoimmune bullous diseases with autoantibodies directed to desmosomal proteins mostly desmogleins 1 and 3 and rarely other keratinocytic proteins. The two main subgroups are pemphigus foliaceus with subcorneal blisters and desmoglein 1 autoantibodies and pemphigus vulgaris with suprabasilar acantholysis and anti-desmoglein 3 and less commonly anti-desmoglein 1 autoantibodies. The following seven pemphigus types including vegetans, herpetiformis, erythematosus, paraneoplastic, drug-induced, IgA, and IgA/IgG are variants of the main subgroups. In the second group of disorders with acantholysis and Hailey-Hailey and Darier diseases, genetic defect is responsible for desmosomal instability with or without abnormal keratinization. The last entity, Grover disease, is acquired with late-onset transient acantholytic dermatosis that histopathologically resembles autoimmune or genetic acantholytic disorders without circulating autoantibodies and known genetic background.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Xuan RR, Yang A, Murrell DF. New biochip immunofluorescence test for serological diagnosis of pemphigus vulgaris and foliaceus: a review of the literature. Int J Womens Dermatol. 2018;4(2):102–8.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Ruocco V, Ruocco E, Lo Schiavo A, Brunetti G, Guerrera LP, Wolf R. Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies. Clin Dermatol. 2013;31(4):374–81.

    Article  PubMed  Google Scholar 

  3. Bastuji-Garin S, Souissi R, Blum L, et al. Comparative epidemiology of pemphigus in Tunesia and France: unusual incidence of pemphigus foliaceus in young Tunisian women. J Invest Dermatol. 1995;104(2):302–5.

    Article  CAS  PubMed  Google Scholar 

  4. Lombardi C, Borges PC, Chaul A, et al. Environmental risk factors in endemic pemphigus foliaceus (fogo selvagem). “The Cooperative Group on Fogo Selvagem Research”. J Invest Dermatol. 1992;98(6):847–50.

    Article  CAS  PubMed  Google Scholar 

  5. Shirakata Y, Amagai M, Hanakawa Y, Nishikawa T, Hashimoto K. Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of Desmoglein 1. J Invest Dermatol. 1998;110(1):76–8.

    Article  CAS  PubMed  Google Scholar 

  6. Murrell DF, Pena S, Joly P, Marinovic B, Hashimoto T, Diaz LA, et al. Diagnosis and management of pemphigus: recommendations by an international panel of experts. J Am Acad Dermatol. 2018;pii: S0190-9622(18)30207-X.

    Google Scholar 

  7. Dmochowski M, Gornowicz-Porowska J, Bowszyc-Dmochowska M. Dew drops on spider web appearance: a newly named pattern of IgG4 deposition in pemphigus with direct immunofluorescence. Postepy Dermatol Alergol. 2017;34(4):295–8.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Bystryn JC, Rudolph JL. Pemphigus. Lancet. 2005;366(9479):61–73.

    Article  PubMed  Google Scholar 

  9. Dmochowski M. Naturalne otwory ciała i błony śluzowe w pęcherzycy zwykłej [Natural body orifices and mucous membranes in pemphigus vulgaris]. Dermatologia Kliniczna. 2007;9(2):124–31.

    Google Scholar 

  10. Yesudian PD, Krishnan SGS, Jayaraman M, Janaki VR, Yesudian P. Postpemphigus acanthomata: a sign of clinical activity? Int J Dermatol. 1997;36(3):194–6.

    Article  CAS  PubMed  Google Scholar 

  11. Venugopal SS, Murrell DF. Diagnosis and clinical features of pemphigus vulgaris. Dermatol Clin. 2011;29(3):373–80.

    Article  CAS  PubMed  Google Scholar 

  12. Alexandru A, Zurac S, Salavastru CM, Andrei R, Tebeica T, et al. Direct immunofluorescence on hair follicles – present and future perspectives. Am J Dermatopathol. 2013;35(4):472–6.

    Article  PubMed  Google Scholar 

  13. Wolnik-Trzeciak G, Hochół A, Bowszyc-Dmochowska M, Dmochowski M. Kliniczne, drobnowidowe i molekularne cechy zajęcia mieszka włosowego w autoimmunizacyjnych dermatozach pęcherzowych [clinical, microscopic and molecular aspects of the hair follicle in autoimmune blistering dermatoses]. Dermatologia Kliniczna. 2006;8(2):114–20.

    Google Scholar 

  14. Giurdanella F, Diercks GF, Jonkman MF, Pas HH. Laboratory diagnosis of pemphigus: direct immunofluorescence remains the gold standard. Br J Dermatol. 2016;175(1):185–6.

    Article  CAS  PubMed  Google Scholar 

  15. Zarra I, Sellami A, Bouguerra C, Sellami MK, Chelly I, et al. Pemphigus vegetans: a clinical, histological, immunopathological and prognostic study. J Eur Acad Dermatol Venereol. 2011;25(10):1160–7.

    Article  Google Scholar 

  16. Ruocco V, Ruocco E, Caccavale S, Gambardella A, Schiavo AL. Pemphigus vegetans of the folds (intertriginous areas). Clin Dermatol. 2015;33(4):471–6.

    Article  PubMed  Google Scholar 

  17. Jabłońska S, Chorzelski TP, Beutner EH, Chorzelska J. Herpetiform pemphigus, a variable pattern of pemphigus. Int J Dermatol. 1975;14(5):353–9.

    Article  PubMed  Google Scholar 

  18. Ishii K, Amagai M, Komai A, Ebihara T, Chorzelski TP, et al. Desmoglein 1 and desmoglein 3 are the target autoantigens in herpetiform pemphigus. Arch Dermatol. 1999;135(8):943–7.

    Article  CAS  PubMed  Google Scholar 

  19. Tateishi C, Tsuruta D, Nakanishi T, Uehara S, Kobayashi H, et al. Antidesmocollin-1 antibody-positive, antidesmoglein antibody-negative pemphigus herpetiformis. J Am Acad Dermatol. 2010;63(1):e8–10.

    Article  PubMed  Google Scholar 

  20. Porro AM, de Vasconcelos Nasser Caetano L, de Sena Nogueira Maehara L, dos Santos Enokihara MM. Non-classical forms of pemphigus: pemphigus herpetiformis, IgA pemphigus, paraneoplastic pemphigus and IgG/IgA pemphigus. An Bras Dermatol. 2014;89(1):96–106.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Maciejowska E, Jabłońska S, Chorzelski T. Is pemphigus herpetiformis an entity? Int J Dermatol. 1987;26(9):571–7.

    Article  CAS  PubMed  Google Scholar 

  22. Peterman CM, Vadeboncoeur S, Schmidt BA, Gellis SE. Pediatric pemphigus herpetiformis: case report and review of the literature. Pediatr Dermatol. 2017;34(3):342–6.

    Article  PubMed  Google Scholar 

  23. Koga H, Ishii N, Hashimoto T, Nakama T. Case of shift from linear immunoglobulin A bullous dermatosis to pemphigus herpetiformis for a short period of time. J Dermatol. 2017;44(2):189–93.

    Article  CAS  PubMed  Google Scholar 

  24. Senear FE, Usher B. An unusual type of pemphigus combining features of lupus erythematosus. Arch Derm Syphilol. 1926;13(6):761–81.

    Article  Google Scholar 

  25. Steffen C, Thomas CD. The man behind the eponym Frances E Senear, Barney Usher, and the Senear-Usher syndrome. Am J Dermatopathol. 2003;25(5):432–6.

    Article  PubMed  Google Scholar 

  26. Chorzelski TP, Jabłońska S, Błaszczyk M. Immunopatholgical investigations in the Senear-Usher syndrome (coexistence of pemphigus and lupus erythematosus). Br J Dermatol. 1968;80(4):211–7.

    Article  CAS  PubMed  Google Scholar 

  27. Oktarina DAM, Poot AM, Kramer D, Diercks GF, Jonkman MF, Pas HH. The IgG “lupus-band” deposition pattern of pemphigus erythematosus association with the desmoglein ectodomain as revealed by 3 cases. Arch Dermatol. 2012;148(10):1173–8.

    Article  PubMed  Google Scholar 

  28. Hacker-Foegen MK, Janson M, Amagai M, Fairley JA, Lin MS. Pathogenicity and epitope characteristics of anti-desmoglein-1 from pemphigus foliaceus patients expressing only IgG1 autoantibodies. J Invest Dermatol. 2003;121(6):1373–8.

    Article  CAS  PubMed  Google Scholar 

  29. Basler RS. Senear-Usher syndrome with parathyroid adenoma. Br J Dermatol. 1974;91(4):465–7.

    Article  CAS  PubMed  Google Scholar 

  30. Amerian ML, Ahmed AR. Pemphigus erythematosus. J Am Acad Dermatol. 1984;10(2 Pt 1):215–22.

    Article  CAS  PubMed  Google Scholar 

  31. Chavan SA, Sharma YK, Deo K, Buch AC. A case of Senear-Usher syndrome. Indian J Dermatol. 2013;58(4):329.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med. 1990;323(25):1729–35.

    Article  CAS  PubMed  Google Scholar 

  33. Seishima M, Oda M, Oyama Z, Yoshimura T, Yamazaki F, Aoki T, et al. Antibody titers to desmoglein 1 and 3 in a patient with paraneoplastic pemphigus associated with follicular dendritic cell sarcoma. Arch Dermatol. 2004;140(12):1500–3.

    Article  PubMed  Google Scholar 

  34. Konichi-Dias RL, Ramos AF, de Almeida Santos Yamashita ME, Carcano CBM. Paraneoplastic pemphigus associated with chronic lymphocytic leukemia: a case report. J Med Case Reports. 2018;12(1):252. https://doi.org/10.1186/s13256-018-1742-8.

    Article  Google Scholar 

  35. Ohzono A, Sogame R, Li X, et al. Clinical and immunological findings in 104 cases of paraneoplastic pemphigus. Br J Dermatol. 2015;173(6):1447–52.

    Article  CAS  PubMed  Google Scholar 

  36. Nguyen VT, Ndoye A, Bassler KD, Shultz LD, Shieldc MC, Ruben BS, et al. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. Arch Dermatol. 2001;137(2):193–206.

    CAS  PubMed  Google Scholar 

  37. Horn TD, Anhalt GJ. Histologic features of paraneoplastic pemphigus. Arch Dermatol. 1992;128(8):1091–5.

    Article  CAS  PubMed  Google Scholar 

  38. Poot AM, Siland J, Jonkman MF, Pas HH, Diercks GF. Direct and indirect immunofluorescence staining patterns in the diagnosis of paraneoplastic pemphigus. Br J Dermatol. 2016;174(4):912–5.

    Article  CAS  PubMed  Google Scholar 

  39. Degos R, Touraine R, Belaich S, Revuz J. Pemphigus in a patient treated with penicillamine for Wilson’s disease [article in French]. Bull Soc Fr Dermatol Syphiligr. 1969;76(6):751–3.

    CAS  PubMed  Google Scholar 

  40. Maruani A, Machet MC, Carlotti A, Giraudeau B, Vaillant L, Machet L. Immunostaining with antibodies to desmoglein provides the diagnosis of drug-induced pemphigus and allows prediction of outcome. Am J Clin Pathol. 2008;130(3):369–74.

    Article  PubMed  Google Scholar 

  41. Ruocco E, Aurilia A, Ruocco V. Precautions and suggestions for pemphigus patients. Dermatology. 2001;203(3):201–7.

    Article  CAS  PubMed  Google Scholar 

  42. Baroni A, Russo T, Faccenda F, Piccolo V. Amoxicillin/clavulanic acid-induced pemphigus vulgaris: case report. Acta Dermatovenerol Croat. 2012;20(2):108–11.

    CAS  PubMed  Google Scholar 

  43. Pietkiewicz P, Gornowicz-Porowska J, Bowszyc-Dmochowska M, Dmochowski M. A retrospective study of antihypertensives in pemphigus: a still unchartered odyssey particularly between thiols, amides and phenols. Arch Med Sci. 2015;11(5):1021–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Brenner S, Srebrnik A, Goldberg I. Pemphigus can be induced by topical phenol as well as foods and drugs that contain phenols and thiols. J Cosmet Dermatol. 2003;2(3–4):161–5.

    Article  CAS  PubMed  Google Scholar 

  45. Brenner S, Goldberg I. Drug-induced pemphigus. Clin Dermatol. 2011;29(4):455–7.

    Article  PubMed  Google Scholar 

  46. Wang J, Kwon J, Ding X, Fairley JA, Woodley DT, Chan LS. Nonsecretory IgA1 autoantibodies targeting desmosomal component desmoglein 3 in intraepidermal neutrophilic IgA dermatosis. Am J Pathol. 1997;150(6):1901–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Hashimoto T, Ebihara T, Dmochowski M, Kawamura K, Suzuki T, Tsurufuji S, et al. IgA antikeratinocyte surface autoantibodies from two types of intercellular IgA vesiculopustular dermatosis recognize distinct isoforms of desmocollin. Arch Dermatol Res. 1996;288(8):447–52.

    CAS  PubMed  Google Scholar 

  48. Tajima M, Mitsuhashi Y, Irisawa R, Amagai M, Hashimoto T, Tsuboi R. IgA pemphigus reacting exclusively to desmoglein 3. Eur J Dermatol. 2010;20(5):626–9.

    PubMed  Google Scholar 

  49. Hashimoto T, Teye K, Ishii N. Clinical and immunological studies of 49 cases of various types of intercellular IgA dermatosis and 13 cases of classical subcorneal pustular dermatosis examined at Kurume University. Br J Dermatol. 2017;176(1):168–75.

    Article  CAS  PubMed  Google Scholar 

  50. Wallach D. Intraepidermal IgA pustulosis. J Am Acad Dermatol. 1992;27(6 Pt 1):993–1000.

    Article  CAS  PubMed  Google Scholar 

  51. Sood A, Sinha P, Raman DK, Sinha A. Imatinib-induced IgA pemphigus: subcorneal pustular dermatosis type. Indian Dermatol Online J. 2018;9(5):331–3.

    PubMed  PubMed Central  Google Scholar 

  52. Kishimoto K, Iwatsuki K, Akiba H, Motoki Y, Kaneko F. Subcorneal pustular dermatosis – type IgA pemphigus induced by thiol drugs. Eur J Dermatol. 2001;11(1):41–4.

    CAS  PubMed  Google Scholar 

  53. Oiso N, Yamashita C, Yoshioka K, Amagai M, Komai A, Nagata Y, et al. IgA/IgG pemphigus with IgG and IgA antidesmoglein 1 antibodies detection by enzyme-linked immunosorbent assay. Br J Dermatol. 2002;147(5):1012–7.

    Article  CAS  PubMed  Google Scholar 

  54. Heng A, Nwaneshiudu A, Hashimoto T, Amagai M, Stanley JR. Intraepidermal neutrophilic IgA/IgG antidesmocollin 1 pemphigus. Br J Dermatol. 2006;154(5):1018–20.

    Article  CAS  PubMed  Google Scholar 

  55. Kowalewski C, Hashimoto T, Amagai M, Jabłońska S, Mackiewicz W, Woźniak K. IgA/IgG pemphigus: a new atypical subset of pemphigus? Acta Derm Venereol. 2006;86(4):357–8.

    Article  PubMed  Google Scholar 

  56. Cetkovská P, Komorousová M, Lomicová I. Management of pemphigus with IgA and IgG antibodies and coexistent lung cancer. Dermatol Ther. 2014;27(4):236–9.

    Article  PubMed  Google Scholar 

  57. Maruyama H, Kawachi Y, Fujisawa Y, Itoch S, Ishi Y, et al. IgA/IgG pemphigus positive for anti-desmoglein 1 antibody. Eur J Dermatol. 2007;17(1):94–5.

    PubMed  Google Scholar 

  58. Uchiyama R, Ishi N, Arakura F, Kiniwa Y, Nakazawa K, et al. IgA/IgG pemphigus with infiltration of neutrophils and eosinophils in an ulcerative colitis patient. Acta Derm Venereol. 2014;94(6):737–8.

    Article  PubMed  Google Scholar 

  59. Hashimoto T, Teye K, Hashimoto K, Wozniak K, Ueo D, et al. Clinical and immunological study of 30 cases with both IgA and IgG anti-keratinocyte cell surface autoantibodies toward the definition of intercellular IgA/IgG dermatosis. Front Immunol. 2018;9:994. https://doi.org/10.3389/fimmu.2018.00994.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Bruckner AL, Fitzpatrick JE, Hashimoto T, Weston WL, Morelli JG. Atypical IgA/IgG pemphigus involving the skin, oral mucosa and colon in a child: a novel variant of IgA pemphigus? Pediatr Dermatol. 2005;22(4):321–7.

    Article  PubMed  Google Scholar 

  61. Toosi S, Collins JW, Lohse CM, et al. Clinicopathologic features of IgG/IgA pemphigus in comparison with classic (IgG) and IgA pemphigus. Int J Dermatol. 2016;55(4):e184–90.

    Article  CAS  PubMed  Google Scholar 

  62. Burge SM. Hailey-Hailey disease: the clinical features, response to treatment and prognosis. Br J Dermatol. 1992;126(3):275–82.

    Article  CAS  PubMed  Google Scholar 

  63. Hu Z, Bonifas JM, Beech J, Bench G, Shigihara T, et al. Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat Genet. 2000;24(1):61–5.

    Article  CAS  PubMed  Google Scholar 

  64. Engin B, Kutlubay Z, Celik U, Serdaroglu S, Tuzun Y. Hailey-Hailey disease: a fold (intertriginous) dermatosis. Clin Dermatol. 2015;33(4):452–5.

    Article  PubMed  Google Scholar 

  65. Kelati A, Argenziano G, Mernissi FZ. Dermoscopic presentation of Hailey-Hailey disease. J Am Acad Dermatol. 2017;76(2S1):S31–3.

    Article  PubMed  Google Scholar 

  66. Bel B, Jeudy G, Vabres P. Dermoscopy of longitudinal leukonychia in Hailey-Hailey disease. Arch Dermatol. 2010;146(10):1204.

    Article  PubMed  Google Scholar 

  67. See SHC, Petemel S, Adams D, North JP. Distinguishing histopathologic features of acantholytic dermatoses and the pattern of acantholytic hypergranulosis. J Cutan Pathol. 2019;46(1):6–15.

    Article  PubMed  Google Scholar 

  68. Vodo D, Malchin N, Furman M, Sarig O, Sprecher E. Identification of a recurrent mutation in ATP2C1 demonstrates that papular acantholytic dyskeratosis and Hailey-Hailey disease are allelic disorders. Br J Dermatol. 2018;179(4):1001–2.

    Article  CAS  PubMed  Google Scholar 

  69. Takagi A, Kamijo M, Ikeda S. Darier disease. J Dermatol. 2016;43(3):275–9.

    Article  CAS  PubMed  Google Scholar 

  70. Sakuntabhai A, Ruiz-Perez V, Carter S, Jacobsen N, Burge S, et al. Mutations in ATP2A2, encoding Ca2+pump, cause Darier disease. Nat Genet. 1999;21(3):271–7.

    Article  CAS  PubMed  Google Scholar 

  71. Garcia-Morales I, Case-Mérida S, Escudero J. Kaposi’s varicelliform eruption in a patient with Darier’s disease. Indian J Dermatol. 2018;63(5):434–5.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Bergman R, Sezin T, Indelman M, Helou WA, Avitan-Hersh E. Acrokeratosis verruciformis of Hopf showing P602L mutation in ATP2A2 and overlapping histopathological features with Darier disease. Am J Dermatopathol. 2012;34(6):597–601.

    Article  PubMed  Google Scholar 

  73. Lacarrubba F, Versi AE, Errichetti E, Stinco G, Micali G. Darier disease: dermoscopy, confocal microscopy and histologic correlations. J Am Acad Dermatol. 2015;73(3):e97–9.

    Article  PubMed  Google Scholar 

  74. Huh WK, Fujiwara K, Takahashi H, Kanitakis J. Congenital acantholytic dyskeratotic epidermal naevus following Blaschko’s lines versus segmental Darier’s disease. Eur J Dermatol. 2007;17(2):130–2.

    CAS  PubMed  Google Scholar 

  75. Uemura M, Faisal F, Haymaker C, McQuail N, Sirmans E, et al. A case report of Grover’s disease from immunotherapy – a skin toxicity induced by inhibition of CTLA-4 but not PD-1. J Immunother Cancer. 2016;4:55. https://doi.org/10.1186/s40425-016-0157-6.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Gantz M, Butler D, Goldberg M, Ryu J, McCalmont T, Shinkai K. Atypical features and systemic associations in extensive cases of Grover disease: a systemic review. J Am Acad Dermatol. 2017;77(5):952–7.

    Article  PubMed  Google Scholar 

  77. De Abreu L, Guimães Cordeiro N, Mota Buçard A, Carvalho Quintella D, Argenziano G. Dermoscopy of grover disease. J Am Acad Dermatol. 2017;76(2S1):S60–3.

    Article  PubMed  Google Scholar 

  78. Melwani PM, Parsons AC, Sangueza OP. Early histopathologic changes in Grover disease. Am J Dermatopathol. 2010;32(6):565–7.

    Article  PubMed  Google Scholar 

  79. Fernández-Figueras M-T, Puig L, Cannata P, Cuatrecases M, Quer A, Ferrándiz C, Ariza A. Grover disease: a reappraisal of histopathological diagnostic criteria in 120 cases. Am J Dermatopathol. 2010;32(6):541–9.

    Article  PubMed  Google Scholar 

  80. Aljarbou OZ, Asgari M, Al-Saidi N, Silloca-Cabana EO, Alathamneh M, Sangueza OP. Grover disease with epidermal dysmaturation pattern: a common histopathologic finding. Am J Dermatopathol. 2018;40(9):642–6.

    Article  PubMed  Google Scholar 

  81. Brenner S, Mashiah J, Tamir E, Goldberg I, Wohl Y. PEMPHIGUS: an acronym for disease with multiple etiologies. Skinmed. 2003;2(3):163–7.

    Article  PubMed  Google Scholar 

  82. Anadolu RY, Birol A, Bostanci S, Boyvat A. A case of pemphigus vulgaris possibly triggered by quinolones. J Eur Acad Dermatol Venereol. 2002;16(2):152–3.

    Article  CAS  PubMed  Google Scholar 

  83. Wolf R, Tamir A, Brenner S. Drug-induced versus drug-triggered pemphigus. Dermatologica. 1991;182(4):207–10.

    Article  CAS  PubMed  Google Scholar 

  84. Hoyt B, Bhawn J. Histological spectrum of cutaneous herpes infections. Am J Dermatopathol. 2014;36(8):609–16.

    Article  PubMed  Google Scholar 

  85. Medeiros PM. Segmental Darier’s disease: a presentation of difficult diagnosis. Ann Bras Dermatol. 2015;90(3 suppl 1):62–5.

    Article  Google Scholar 

  86. Sakuntabhai A, Dhitavat J, Burge S, Hovnanian A. Mosacism for ATP2A2 mutations causes segmental Darier’s disease. J Invest Dermatol. 2000;115(6):1144–7.

    Article  CAS  PubMed  Google Scholar 

  87. Folster-Holst R, Nellen RG, Jensen JM, Poblete-Gutierrez P, Steijlen PM, et al. Molecular genetic support for the rule of dichotomy in type 2 segmental Darier disease. Br J Dermatol. 2012;166(2):464–6.

    Article  CAS  PubMed  Google Scholar 

  88. Thappa DM. The isomorphic phenomenon of Koebner. Indian J Dermatol Venereol Leprol. 2004;70(3):187–9.

    Article  PubMed  Google Scholar 

  89. Chorzelski TP, Kudejko J, Jabłońska S. Is papular acantholytic dyskeratosis of the vulva a new entity? Am J Dermatopathol. 1984;6(6):557–60.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marian Dmochowski .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bowszyc-Dmochowska, M., Hoang, M.P., Dmochowski, M. (2020). Subcorneal and Intraepidermal Immunobullous Dermatoses. In: Hoang, M., Selim, M. (eds) Hospital-Based Dermatopathology. Springer, Cham. https://doi.org/10.1007/978-3-030-35820-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-35820-4_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-35819-8

  • Online ISBN: 978-3-030-35820-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics